Frrol, you sure are assuming a lot there. My first explanation for the mono group not being on soc would be because the side effects from donzepil were too extreme. I believe only half AD patients can handle these side effects enough to continue taking donzepil. Any who, just saying, I don't think you can assume mono group was least impaired.
Market Data 
Markets 
AI
